View Clinical Trial (Medical Research Study)
A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
| City: |
|
Jacksonville |
| State: |
|
Florida |
| Zip Code: |
|
32206 |
| Conditions: |
|
Pancreatic Cancer |
| Purpose: |
|
The purpose of this study is to find out what effects, good and/or bad, proton radiation
combined with chemotherapy and surgery has on you and your pancreatic cancer. This study
will look at the side effects from the treatment and the quality of your life in relation to
pain. It will also look at how the tumor responds to the combination of treatment with
radiation, chemotherapy and surgery.
|
| Study Summary: |
|
Chemotherapy capecitabine on radiation days
Proton radiation over 6 weeks
Surgery 6 weeks after radiation completion
Adjuvant Chemotherapy starting 2-8 weeks after surgery with Gemzar
|
| Criteria: |
|
Inclusion Criteria:
- Pathologically confirmed adenocarcinoma of the pancreas.
- Patients must have marginally resectable disease.
- Patients with biliary obstruction must have adequate drainage prior to starting
chemoradiation.
Exclusion Criteria:
- Evidence of distant metastasis including peritoneal seeding and/or ascites.
- Previous irradiation to the abdomen that would compromise the ability to deliver the
prescribed treatment.
- Prior surgical resection.
- Gastroduodenal obstruction
|
| NCT ID: |
|
NCT00763516 |
| Primary Contact: |
|
Principal Investigator
Romaine C Nichols, MD
University of Florida Proton Therapy Institute
Intake Coordinator
Phone: 877-686-6009
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Jacksonville, Florida 32206
United States
Intake Coordinator
Phone: 877-686-6009
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|